These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The association of platelet and red cell count with platelet impedance changes in whole blood and light-scattering changes in platelet rich plasma: evidence from the Caerphilly Collaborative Heart Disease Study. Sharp DS; Beswick AD; O'Brien JR; Renaud S; Yarnell JW; Elwood PC Thromb Haemost; 1990 Oct; 64(2):211-5. PubMed ID: 2270530 [TBL] [Abstract][Full Text] [Related]
10. High residual platelet reactivity (HRPR) for adenosine diphosphate (ADP) stimuli is a determinant factor for long-term outcomes in acute ischemic stroke with anti-platelet agents: The meaning of HRPR after ADP might be more prominent in large atherosclerotic infarction than other subtypes of AIS. Cha JK; Park HS; Nah HW; Kim DH; Kang MJ; Choi JH; Huh JT; Suh HK J Thromb Thrombolysis; 2016 Jul; 42(1):107-17. PubMed ID: 26680778 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up. Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249 [TBL] [Abstract][Full Text] [Related]
13. Predictive value of high residual platelet reactivity by flow cytometry for outcomes of ischemic stroke patients on clopidogrel therapy. Qiu LN; Wang L; Li X; Han RF; Xia XS; Liu J J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1145-52. PubMed ID: 25869773 [TBL] [Abstract][Full Text] [Related]